 |
인쇄하기
취소
|
KFDA approved clinical trials on adult stem cell therapy.
Sewon Cellontech announced that the KFDA approved their cellular therapy, Ostem, after differentiating stem cells into myeloblasts on Dec. 19, which will be the first commercialized case in the world.
The previous studies reported to make osteocytes by differentiating adult stem cells isolated from bone marrows at a laboratory level, and never succeeded in its commercial preparations, but S...
The previous studies reported to make osteocytes by differentiating adult stem cells isolated from bone marrows at a laboratory level, and never succeeded in its commercial preparations, but S...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.